Rani Therapeutics is developing a novel approach for the oral delivery of large drug molecules, which to date can only be delivered through injections. Our investors include Google Ventures, InCube Ventures and VentureHealth.
The approach and technology for Rani Therapeutics was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations. InCube is led by Mir Imran, a prolific medical inventor, entrepreneur and investor.